Directory Gematotropona funds Coagulants (including factors such as blood clotting), gemostatiki Gemofil m
This page is translated automatically with a help of Google Translate

Gemofil m

See also Antihemophilic factor viii

Roman name

Hemofil M

The composition and the form of

1 bottle with sterile, apirogennam, liofilizirovannam powders for the preparation of injection solution includes factors such as blood clotting VIII 200-300, 400-600 or 800-1200 IU, together with the solvent-water injection in vials of 10 ml, bilateral needle and the needle filter; in a carton 21.90.

Of drugs

Gemostaticescoe, complementary deficit reduction factor VIII. Fills deficit antigemofilland factor.

Indications

Hemophilia A (classical), a breach of hemostasis caused by circulating inhibitors factor VIII (if their level does not exceed 10 Bethesda U / ml).

Contraindications

Hypersensitivity, illness Villebranda background.

Side-Effects

Rarely, nausea, feverish condition, chills, urticaria.

Dosing and Administration

In / in, and at speeds of 2-3 mL / min. The mode set individually controlled activity factor out VIII. The joint, muscle and tissue artistic methods level of factor VIII increase to a range of 10 to 20% (treatment duration of not less than 2-3 days); Teeth extraction or small transactions, not less than 30% (5 days), gastrointestinal artistic methods, not less than 50% (10-14 days); Extensive surgical interventions or intracranial krovoislianiah at no less than 60% (2-3 weeks). Initial dose (IU) looks as the product of the desired increase in the content of factor VIII (%), for weight (kg), which supports the dose is half primary. To prevent prolonged bleeding with severe hemophilia A, 12-25 IU / kg every 2-3 days.

Storage conditions

por.liof.d / in. : List B. The temperature of 2-30 ° C (not freezing). Avoid freezing liquids for breeding.

Shelf life

por.liof.d / in. : 2, 6 months

All products of this group